2H-3-Benzoxecin-2,8(1H)-dione,4,5-dihydro-9,11-dihydroxy-4-methyl-, (4S,6E)- (122588-63-0)

Identification
Name:	2H-3-Benzoxecin-2,8(1H)-dione,4,5-dihydro-9,11-dihydroxy-4-methyl-, (4S,6E)-
Synonyms:	(-)-Sporostatin;M 5032; Sporostatin
CAS:	122588-63-0
Molecular Formula:	C14H14 O5
Molecular Weight:	262.258
InChI:	InChI=1/C14H14O5/c1-8-3-2-4-11(16)14-9(6-13(18)19-8)5-10(15)7-12(14)17/h2,4-5,7-8,15,17H,3,6H2,1H3/b4-2-
Molecular Structure:
Properties
Flash Point:	220.8°C
Boiling Point:	568.4°C at 760 mmHg
Density:	1.302g/cm³
Refractive index:	1.577
Flash Point:	220.8°C
Safety Data

Other Product

1-Oxa-7-azaspiro[5.5]undecan-8-one,2-[(2R,- 3R,6E,8E,10S,12E,14E)-2,10-dihydroxy-3,9- dimethyl-15-[(2S,3R,4R,5R)-tetrahydro-4- hydroxy-3-methyl-6-oxo-5-(3-oxobutyl)- 2H-pyran-2-yl]-6,8,12,14-pentadecatetraenyl]- 9-ethyl-4-hydroxy-3,5,11- trimethyl-,(2S,3R,4S,5S,6R,9S,11S)-
3H,10H-Furo[2,3,4-mn][3]benzoxecin-3,10- dione,2-(1E,3E,5E)-1,3,5-heptatrienyl-5,6,7,- 8,9,9a,12a,12b-octahydro-7,9-dihydroxy-5- methyl-,(9aR,12aS,12bS)-(+)-
3H,10H-Furo[2,3,4-mn][3]benzoxecin-3,10- dione,2-(1E,3Z,5E)-1,3,5-heptatrienyl-5,6,7,- 8,9,9a,12a,12b-octahydro-7,9-dihydroxy-5- methyl-,(9aR,12aS,12bS)-rel-
2,4,11-Trioxa-12-silatetradec-6-ene,5-[(4S)-5-[(2R,6R)-3,6-dihydro-6-[3-(trimethylsilyl)-2-propynyl]-2H-pyran-2-yl]-4-methyl-2-methylenepentyl]-9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-10-ethenyl-12,12,13,13-tetramethyl-, (5S,6E,9S,10S)-
2H-3-Benzoxacyclododecin-2,10(1H)-dione,4,5,6,7,8,9-hexahydro-11,13-dihydroxy-4-methyl-, (4S)-
2H-3-Benzoxacyclododecin-2,10(1H)-dione,4,5,6,7-tetrahydro-11,13-dihydroxy-4-methyl-, (4S,8E)-
Benzoic acid,2,4-dihydroxy-,2-(5,6-dihydro-9-hydroxy-2-methyl-2,6-methano-2H-1-benzoxocin-4-yl)-5a,10a-dihydro-1,5a,8-trihydroxy-10a-(3-methyl-2-butenyl)-11-oxo-11H-benzofuro[3,2-b][1]benzopyran-3-ylester (9CI)
4-[(1E,2E,4R,6E)-8-[(2R,4S,6R,8R,9S)-8-Ethyl-4-hydroxy-9-methyl-1,7-dioxaspiro[5.5]undec-2-yl]-4,6-dimethyl-2,6-octadienylidene]-3,4-dihydro-7-methyl-1H-2-benzopyran-1-one
3,4-Dihydro-4-[(1E,2E,4R,6E)-8-[(2R,4S,6R,8R,9S)-4-hydroxy-9-methyl-8-(1-methylethyl)-1,7-dioxaspiro[5.5]undec-2-yl]-4,6-dimethyl-2,6-octadienylidene]-7-methyl-1H-2-benzopyran-1-one
2(3H)-Furanone,dihydro-4-(hydroxymethyl)-5-[(2Z,6E)-3-(hydroxymethyl)-7-methyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,6-nonadien-1-yl]-,(4S,5R)-
Spiro[1H-cyclopenta[b]pyrrolo[1,2-a]azepine-11(10H),2'(5'H)-furan]-5',10-dione,2,3,5,6,7,8-hexahydro-3'-methoxy-4',9-dimethyl-3-[(2S,4S)-tetrahydro-4-methyl-5-oxo-2-furanyl]-,(2'S,3S,11aR)-
6-Nonenenitrile,4-methyl-8-oxo-3-(phenylmethoxy)-5-[(phenylmethoxy)methoxy]-,(3R,4S,5S,6E)-
Spiro[oxirane-2,8'-[8H-4,8a]propano[1H-2]benzopyran]-10'-one,4'-[(2S)-2-(acetyloxy)-2-(3-furanyl)ethyl]hexahydro-3',9'-dihydroxy-11'-methyl-,(2R,3'S,4'S,4'aS,8'aR,9'R,11'S)- (9CI)
4-[(3-carboxy-2-hydroxy-naphthalen-1-yl)methyl]-3-hydroxy-naphthalene-2-carboxylic acid; 2-[(2R,4E,6E,8R,9R,11R,12S,13S,14R)-12-[(2S,3R,4S,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyl-oxan-2-yl]oxy-4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl]oxy-8-[(2R,5S,6R)-5-dimethylamino-6-methyl-oxan-2-yl]oxy-14-hydroxy-13-methoxy-2,9-dimethyl-16-oxo-1-oxacyclohexadeca-4,6-dien-11-yl]acetaldehyde
2H-Oxireno[e][1]benzoxecin,8-bromo-4-ethenyldodecahydro-4,5a,9,9,11a-pentamethyl- (9CI)
9-methyl-2-(3-morpholin-4-ylpropyl)-4,9-dihydro-1H-beta-carboline-1,3(2H)-dione
(6R,1’E,3’R,4’R,6’R,7’Z,9’Z,11’E)-6-(6’-tert-butyldimethylsiloxy-13’-tert-butyldiphenylsiloxy-3’,4’-dihydroxy-3’-methyl-1’,7’,9’,11’-tridecatetraenyl)-5,6-dihydro-2H-pyran-2-one
1/C7H10N4O/c1-2-9-10-7(8-1)11-3-5-12-6-4-11/h1-2H,3-6H
4a,9a-Epoxyanthracene-1,10(2H,9H)-dione,4-[(1R)-1-(acetyloxy)ethyl]-7-[5-[(1R)-1-(acetyloxy)ethyl]-9,10-dihydro-1,8-dihydroxy-6-methyl-9,10-dioxo-2-anthracenyl]-3,4-dihydro-3,8,9-trihydroxy-3-methyl-,(3S,4S,4aR,9R,9aR)- (9CI)
(-)-3-Chloro-4,6-dihydroxy-2-methyl-5-[(2E,6E)-3-methyl-7-[(2S,4S)-tetrahydro-4-hydroxy-5,5-dimethylfuran-2-yl]-2,6-octadienyl]benzaldehyde